Bios Equity Partners, LP → Lantern Pharma Inc. LTRN

Stake: 4.48% Shares: 571,305 CUSIP: 51654W101 Class: Common Stock, par value $0.0001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

1 13D/G filings on this issuer

0 other filings besides this one

Filer Track Record

1 filings by this filer

0 other filings in the data moat

Short Interest · settle 2026-07-31

DTC 10.09

846,372 shares short · -10.5% vs prior

Post-Filing Returns · since 2026-05-15 on LTRN

+1 day

0.0%

+5 days

0.0%

+30 days

0.0%

+60 days

-14.0%

+90 days

—

+180 days

—

Anchor price 3.57 on closest trading day on/after 2026-05-15. Source: Yahoo Finance daily adj_close (split + dividend adjusted).

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →